Synchrony Financial experienced lower loan growth in preparation for a rule limiting late fees. Nevertheless, core 2025 EPS ...

This was the stock's second consecutive day of losses.

Synchrony Financial closed 1.51% below its 52-week high of $70.93, which the company reached on January 23rd.

Synchrony Financial said on Tuesday it expects lower net revenue for 2025 as spending levels moderate and interest rates dip, ...

Good morning, and welcome to the Synchrony Financial fourth quarter and full year 2024 earnings conference call. Please refer ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

U.S. markets were rebounding at midday from yesterday's big tech selloff caused by advances in artificial intelligence by a ...

Synchrony Financial (NYSE: NYSE:SYF), a leading consumer financial services company, has demonstrated remarkable resilience in the face of regulatory challenges and economic uncertainties. As of ...

Q4 2024 Earnings Call Transcript January 28, 2025 Synchrony Financial misses on earnings expectations. Reported EPS is $1.91 ...

Synchrony Financial (SYF – Research Report), the Financial sector company, was revisited by a Wall Street analyst yesterday. Analyst Donald ...

BTIG analyst Vincent Caintic has maintained their neutral stance on SYF stock, giving a Hold rating yesterday.Invest with Confidence: Follow ...

Synchrony Financial partners with retailers and medical providers to offer promotional financing as well as private-label and co-branded general-purpose credit cards. While the company’s CareCredit ...